RASGRP2 expression has not been studied in relation to AML or MDS, however recently RASGRP2/Rap1 signaling was shown to be functionally linked to the CD38-associated increased CLL cell migration. The gene discussed is RASGRP2; the disease is B-cell chronic lymphocytic leukemia.